Nektar Therapeutics
NKTR
NKTR
348 hedge funds and large institutions have $5.48B invested in Nektar Therapeutics in 2019 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 140 increasing their positions, 109 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
348
Holders Change
+6
Holders Change %
+1.75%
% of All Funds
7.54%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
40
Increased
140
Reduced
109
Closed
31
Calls
$28.1M
Puts
$48.5M
Net Calls
-$20.4M
Net Calls Change
-$59.8M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$74.6M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$21.5M |
| 3 |
D.E. Shaw & Co
New York
|
+$14.2M |
| 4 |
JPMorgan Chase & Co
New York
|
+$13.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$186M |
| 2 |
Morgan Stanley
New York
|
-$19.3M |
| 3 |
BlackRock
New York
|
-$15.6M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.6M |
